nodes	percent_of_prediction	percent_of_DWPC	metapath
Pregabalin—Influenza—Epirubicin—liver cancer	0.000538	0.000544	CcSEcCtD
Pregabalin—Dysphagia—Epirubicin—liver cancer	0.000538	0.000544	CcSEcCtD
Pregabalin—Dehydration—Doxorubicin—liver cancer	0.000536	0.000542	CcSEcCtD
Pregabalin—Eosinophilia—Epirubicin—liver cancer	0.000533	0.000539	CcSEcCtD
Pregabalin—Liver function test abnormal—Doxorubicin—liver cancer	0.000532	0.000538	CcSEcCtD
Pregabalin—Dry skin—Doxorubicin—liver cancer	0.000528	0.000534	CcSEcCtD
Pregabalin—Pancreatitis—Epirubicin—liver cancer	0.000528	0.000533	CcSEcCtD
Pregabalin—Vomiting—Sorafenib—liver cancer	0.000527	0.000532	CcSEcCtD
Pregabalin—Orthostatic hypotension—Doxorubicin—liver cancer	0.000526	0.000532	CcSEcCtD
Pregabalin—Hypokalaemia—Doxorubicin—liver cancer	0.000525	0.00053	CcSEcCtD
Pregabalin—Angina pectoris—Epirubicin—liver cancer	0.000525	0.00053	CcSEcCtD
Pregabalin—Rash—Sorafenib—liver cancer	0.000522	0.000528	CcSEcCtD
Pregabalin—Dermatitis—Sorafenib—liver cancer	0.000522	0.000527	CcSEcCtD
Pregabalin—Breast disorder—Doxorubicin—liver cancer	0.000521	0.000526	CcSEcCtD
Pregabalin—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000519	0.000524	CcSEcCtD
Pregabalin—Headache—Sorafenib—liver cancer	0.000519	0.000524	CcSEcCtD
Pregabalin—Bronchitis—Epirubicin—liver cancer	0.000518	0.000523	CcSEcCtD
Pregabalin—Nasopharyngitis—Doxorubicin—liver cancer	0.000515	0.000521	CcSEcCtD
Pregabalin—Pancytopenia—Epirubicin—liver cancer	0.000511	0.000517	CcSEcCtD
Pregabalin—Gastritis—Doxorubicin—liver cancer	0.00051	0.000515	CcSEcCtD
Pregabalin—Muscular weakness—Doxorubicin—liver cancer	0.000508	0.000514	CcSEcCtD
Pregabalin—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000508	0.000514	CcSEcCtD
Pregabalin—Dysuria—Epirubicin—liver cancer	0.000504	0.000509	CcSEcCtD
Pregabalin—Neutropenia—Epirubicin—liver cancer	0.000504	0.000509	CcSEcCtD
Pregabalin—Abdominal distension—Doxorubicin—liver cancer	0.000502	0.000507	CcSEcCtD
Pregabalin—Asthma—Doxorubicin—liver cancer	0.000498	0.000503	CcSEcCtD
Pregabalin—Influenza—Doxorubicin—liver cancer	0.000498	0.000503	CcSEcCtD
Pregabalin—Dysphagia—Doxorubicin—liver cancer	0.000498	0.000503	CcSEcCtD
Pregabalin—Pollakiuria—Epirubicin—liver cancer	0.000497	0.000503	CcSEcCtD
Pregabalin—Eosinophilia—Doxorubicin—liver cancer	0.000493	0.000498	CcSEcCtD
Pregabalin—Nausea—Sorafenib—liver cancer	0.000492	0.000497	CcSEcCtD
Pregabalin—Photosensitivity reaction—Epirubicin—liver cancer	0.000491	0.000497	CcSEcCtD
Pregabalin—Weight increased—Epirubicin—liver cancer	0.00049	0.000495	CcSEcCtD
Pregabalin—Pancreatitis—Doxorubicin—liver cancer	0.000488	0.000494	CcSEcCtD
Pregabalin—Weight decreased—Epirubicin—liver cancer	0.000487	0.000492	CcSEcCtD
Pregabalin—Hyperglycaemia—Epirubicin—liver cancer	0.000486	0.000491	CcSEcCtD
Pregabalin—Angina pectoris—Doxorubicin—liver cancer	0.000485	0.00049	CcSEcCtD
Pregabalin—Pneumonia—Epirubicin—liver cancer	0.000483	0.000488	CcSEcCtD
Pregabalin—Infestation NOS—Epirubicin—liver cancer	0.00048	0.000485	CcSEcCtD
Pregabalin—Infestation—Epirubicin—liver cancer	0.00048	0.000485	CcSEcCtD
Pregabalin—Bronchitis—Doxorubicin—liver cancer	0.000479	0.000484	CcSEcCtD
Pregabalin—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000476	0.000481	CcSEcCtD
Pregabalin—Pancytopenia—Doxorubicin—liver cancer	0.000473	0.000478	CcSEcCtD
Pregabalin—Renal failure—Epirubicin—liver cancer	0.000472	0.000477	CcSEcCtD
Pregabalin—Neuropathy peripheral—Epirubicin—liver cancer	0.000471	0.000475	CcSEcCtD
Pregabalin—Jaundice—Epirubicin—liver cancer	0.000468	0.000473	CcSEcCtD
Pregabalin—Stomatitis—Epirubicin—liver cancer	0.000468	0.000473	CcSEcCtD
Pregabalin—CACNA1A—Calcium Regulation in the Cardiac Cell—GJB1—liver cancer	0.000468	0.0457	CbGpPWpGaD
Pregabalin—Urinary tract infection—Epirubicin—liver cancer	0.000467	0.000472	CcSEcCtD
Pregabalin—Conjunctivitis—Epirubicin—liver cancer	0.000467	0.000472	CcSEcCtD
Pregabalin—Dysuria—Doxorubicin—liver cancer	0.000466	0.000471	CcSEcCtD
Pregabalin—Neutropenia—Doxorubicin—liver cancer	0.000466	0.000471	CcSEcCtD
Pregabalin—Sweating—Epirubicin—liver cancer	0.00046	0.000465	CcSEcCtD
Pregabalin—Pollakiuria—Doxorubicin—liver cancer	0.00046	0.000465	CcSEcCtD
Pregabalin—Haematuria—Epirubicin—liver cancer	0.000458	0.000463	CcSEcCtD
Pregabalin—Photosensitivity reaction—Doxorubicin—liver cancer	0.000455	0.000459	CcSEcCtD
Pregabalin—Weight increased—Doxorubicin—liver cancer	0.000453	0.000458	CcSEcCtD
Pregabalin—Epistaxis—Epirubicin—liver cancer	0.000453	0.000458	CcSEcCtD
Pregabalin—Weight decreased—Doxorubicin—liver cancer	0.000451	0.000455	CcSEcCtD
Pregabalin—Sinusitis—Epirubicin—liver cancer	0.00045	0.000455	CcSEcCtD
Pregabalin—Hyperglycaemia—Doxorubicin—liver cancer	0.000449	0.000454	CcSEcCtD
Pregabalin—Pneumonia—Doxorubicin—liver cancer	0.000447	0.000451	CcSEcCtD
Pregabalin—Infestation NOS—Doxorubicin—liver cancer	0.000444	0.000449	CcSEcCtD
Pregabalin—Infestation—Doxorubicin—liver cancer	0.000444	0.000449	CcSEcCtD
Pregabalin—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00044	0.000445	CcSEcCtD
Pregabalin—Bradycardia—Epirubicin—liver cancer	0.000439	0.000443	CcSEcCtD
Pregabalin—Renal failure—Doxorubicin—liver cancer	0.000437	0.000441	CcSEcCtD
Pregabalin—Neuropathy peripheral—Doxorubicin—liver cancer	0.000435	0.00044	CcSEcCtD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—GLUL—liver cancer	0.000435	0.0424	CbGpPWpGaD
Pregabalin—Haemoglobin—Epirubicin—liver cancer	0.000433	0.000438	CcSEcCtD
Pregabalin—Stomatitis—Doxorubicin—liver cancer	0.000433	0.000437	CcSEcCtD
Pregabalin—Jaundice—Doxorubicin—liver cancer	0.000433	0.000437	CcSEcCtD
Pregabalin—Rhinitis—Epirubicin—liver cancer	0.000432	0.000437	CcSEcCtD
Pregabalin—Urinary tract infection—Doxorubicin—liver cancer	0.000432	0.000436	CcSEcCtD
Pregabalin—Conjunctivitis—Doxorubicin—liver cancer	0.000432	0.000436	CcSEcCtD
Pregabalin—Haemorrhage—Epirubicin—liver cancer	0.000431	0.000435	CcSEcCtD
Pregabalin—Hepatitis—Epirubicin—liver cancer	0.000431	0.000435	CcSEcCtD
Pregabalin—Hypoaesthesia—Epirubicin—liver cancer	0.000429	0.000433	CcSEcCtD
Pregabalin—Pharyngitis—Epirubicin—liver cancer	0.000428	0.000432	CcSEcCtD
Pregabalin—Sweating—Doxorubicin—liver cancer	0.000426	0.00043	CcSEcCtD
Pregabalin—Urinary tract disorder—Epirubicin—liver cancer	0.000426	0.00043	CcSEcCtD
Pregabalin—Oedema peripheral—Epirubicin—liver cancer	0.000425	0.000429	CcSEcCtD
Pregabalin—Haematuria—Doxorubicin—liver cancer	0.000424	0.000428	CcSEcCtD
Pregabalin—Connective tissue disorder—Epirubicin—liver cancer	0.000424	0.000428	CcSEcCtD
Pregabalin—Urethral disorder—Epirubicin—liver cancer	0.000422	0.000427	CcSEcCtD
Pregabalin—Epistaxis—Doxorubicin—liver cancer	0.000419	0.000423	CcSEcCtD
Pregabalin—Sinusitis—Doxorubicin—liver cancer	0.000417	0.000421	CcSEcCtD
Pregabalin—CACNA1A—Type II diabetes mellitus—MTOR—liver cancer	0.000416	0.0406	CbGpPWpGaD
Pregabalin—Visual impairment—Epirubicin—liver cancer	0.000415	0.00042	CcSEcCtD
Pregabalin—Erythema multiforme—Epirubicin—liver cancer	0.000408	0.000412	CcSEcCtD
Pregabalin—Bradycardia—Doxorubicin—liver cancer	0.000406	0.00041	CcSEcCtD
Pregabalin—Eye disorder—Epirubicin—liver cancer	0.000403	0.000407	CcSEcCtD
Pregabalin—Tinnitus—Epirubicin—liver cancer	0.000402	0.000406	CcSEcCtD
Pregabalin—Haemoglobin—Doxorubicin—liver cancer	0.000401	0.000405	CcSEcCtD
Pregabalin—Cardiac disorder—Epirubicin—liver cancer	0.0004	0.000404	CcSEcCtD
Pregabalin—Flushing—Epirubicin—liver cancer	0.0004	0.000404	CcSEcCtD
Pregabalin—Rhinitis—Doxorubicin—liver cancer	0.0004	0.000404	CcSEcCtD
Pregabalin—Hepatitis—Doxorubicin—liver cancer	0.000399	0.000403	CcSEcCtD
Pregabalin—Haemorrhage—Doxorubicin—liver cancer	0.000399	0.000403	CcSEcCtD
Pregabalin—Hypoaesthesia—Doxorubicin—liver cancer	0.000397	0.000401	CcSEcCtD
Pregabalin—Pharyngitis—Doxorubicin—liver cancer	0.000396	0.0004	CcSEcCtD
Pregabalin—Urinary tract disorder—Doxorubicin—liver cancer	0.000394	0.000398	CcSEcCtD
Pregabalin—Oedema peripheral—Doxorubicin—liver cancer	0.000393	0.000397	CcSEcCtD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.000393	0.0384	CbGpPWpGaD
Pregabalin—Connective tissue disorder—Doxorubicin—liver cancer	0.000392	0.000396	CcSEcCtD
Pregabalin—Angiopathy—Epirubicin—liver cancer	0.000391	0.000395	CcSEcCtD
Pregabalin—Urethral disorder—Doxorubicin—liver cancer	0.000391	0.000395	CcSEcCtD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00039	0.0381	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00039	0.0381	CbGpPWpGaD
Pregabalin—Immune system disorder—Epirubicin—liver cancer	0.000389	0.000393	CcSEcCtD
Pregabalin—Mediastinal disorder—Epirubicin—liver cancer	0.000388	0.000392	CcSEcCtD
Pregabalin—Chills—Epirubicin—liver cancer	0.000387	0.000391	CcSEcCtD
Pregabalin—Arrhythmia—Epirubicin—liver cancer	0.000385	0.000389	CcSEcCtD
Pregabalin—Visual impairment—Doxorubicin—liver cancer	0.000384	0.000388	CcSEcCtD
Pregabalin—Alopecia—Epirubicin—liver cancer	0.000381	0.000385	CcSEcCtD
Pregabalin—Mental disorder—Epirubicin—liver cancer	0.000378	0.000382	CcSEcCtD
Pregabalin—Erythema multiforme—Doxorubicin—liver cancer	0.000377	0.000381	CcSEcCtD
Pregabalin—Malnutrition—Epirubicin—liver cancer	0.000375	0.000379	CcSEcCtD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.000375	0.0366	CbGpPWpGaD
Pregabalin—Eye disorder—Doxorubicin—liver cancer	0.000373	0.000377	CcSEcCtD
Pregabalin—Tinnitus—Doxorubicin—liver cancer	0.000372	0.000376	CcSEcCtD
Pregabalin—Flushing—Doxorubicin—liver cancer	0.00037	0.000374	CcSEcCtD
Pregabalin—Cardiac disorder—Doxorubicin—liver cancer	0.00037	0.000374	CcSEcCtD
Pregabalin—Flatulence—Epirubicin—liver cancer	0.00037	0.000374	CcSEcCtD
Pregabalin—Tension—Epirubicin—liver cancer	0.000368	0.000372	CcSEcCtD
Pregabalin—Dysgeusia—Epirubicin—liver cancer	0.000367	0.000371	CcSEcCtD
Pregabalin—Nervousness—Epirubicin—liver cancer	0.000364	0.000368	CcSEcCtD
Pregabalin—Back pain—Epirubicin—liver cancer	0.000363	0.000367	CcSEcCtD
Pregabalin—Angiopathy—Doxorubicin—liver cancer	0.000362	0.000366	CcSEcCtD
Pregabalin—Muscle spasms—Epirubicin—liver cancer	0.000361	0.000364	CcSEcCtD
Pregabalin—Immune system disorder—Doxorubicin—liver cancer	0.00036	0.000364	CcSEcCtD
Pregabalin—Mediastinal disorder—Doxorubicin—liver cancer	0.000359	0.000363	CcSEcCtD
Pregabalin—Chills—Doxorubicin—liver cancer	0.000358	0.000362	CcSEcCtD
Pregabalin—Arrhythmia—Doxorubicin—liver cancer	0.000356	0.00036	CcSEcCtD
Pregabalin—Vision blurred—Epirubicin—liver cancer	0.000354	0.000357	CcSEcCtD
Pregabalin—Alopecia—Doxorubicin—liver cancer	0.000352	0.000356	CcSEcCtD
Pregabalin—CACNA1A—Type II diabetes mellitus—MAPK8—liver cancer	0.000352	0.0343	CbGpPWpGaD
Pregabalin—Mental disorder—Doxorubicin—liver cancer	0.000349	0.000353	CcSEcCtD
Pregabalin—Ill-defined disorder—Epirubicin—liver cancer	0.000348	0.000352	CcSEcCtD
Pregabalin—Malnutrition—Doxorubicin—liver cancer	0.000347	0.000351	CcSEcCtD
Pregabalin—Anaemia—Epirubicin—liver cancer	0.000347	0.00035	CcSEcCtD
Pregabalin—Agitation—Epirubicin—liver cancer	0.000345	0.000348	CcSEcCtD
Pregabalin—Flatulence—Doxorubicin—liver cancer	0.000342	0.000346	CcSEcCtD
Pregabalin—Tension—Doxorubicin—liver cancer	0.000341	0.000344	CcSEcCtD
Pregabalin—Dysgeusia—Doxorubicin—liver cancer	0.00034	0.000343	CcSEcCtD
Pregabalin—Malaise—Epirubicin—liver cancer	0.000338	0.000342	CcSEcCtD
Pregabalin—Nervousness—Doxorubicin—liver cancer	0.000337	0.000341	CcSEcCtD
Pregabalin—Vertigo—Epirubicin—liver cancer	0.000337	0.000341	CcSEcCtD
Pregabalin—Syncope—Epirubicin—liver cancer	0.000336	0.00034	CcSEcCtD
Pregabalin—Leukopenia—Epirubicin—liver cancer	0.000336	0.000339	CcSEcCtD
Pregabalin—Back pain—Doxorubicin—liver cancer	0.000336	0.000339	CcSEcCtD
Pregabalin—Muscle spasms—Doxorubicin—liver cancer	0.000334	0.000337	CcSEcCtD
Pregabalin—SLC1A1—Neuronal System—GLUL—liver cancer	0.000333	0.0325	CbGpPWpGaD
Pregabalin—Palpitations—Epirubicin—liver cancer	0.000332	0.000335	CcSEcCtD
Pregabalin—Loss of consciousness—Epirubicin—liver cancer	0.00033	0.000333	CcSEcCtD
Pregabalin—Cough—Epirubicin—liver cancer	0.000327	0.000331	CcSEcCtD
Pregabalin—Vision blurred—Doxorubicin—liver cancer	0.000327	0.000331	CcSEcCtD
Pregabalin—Convulsion—Epirubicin—liver cancer	0.000325	0.000328	CcSEcCtD
Pregabalin—Hypertension—Epirubicin—liver cancer	0.000324	0.000327	CcSEcCtD
Pregabalin—Ill-defined disorder—Doxorubicin—liver cancer	0.000322	0.000325	CcSEcCtD
Pregabalin—Anaemia—Doxorubicin—liver cancer	0.000321	0.000324	CcSEcCtD
Pregabalin—Myalgia—Epirubicin—liver cancer	0.000319	0.000323	CcSEcCtD
Pregabalin—Chest pain—Epirubicin—liver cancer	0.000319	0.000323	CcSEcCtD
Pregabalin—Arthralgia—Epirubicin—liver cancer	0.000319	0.000323	CcSEcCtD
Pregabalin—Agitation—Doxorubicin—liver cancer	0.000319	0.000322	CcSEcCtD
Pregabalin—Anxiety—Epirubicin—liver cancer	0.000318	0.000322	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000317	0.000321	CcSEcCtD
Pregabalin—Discomfort—Epirubicin—liver cancer	0.000316	0.000319	CcSEcCtD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—GLUL—liver cancer	0.000314	0.0307	CbGpPWpGaD
Pregabalin—Malaise—Doxorubicin—liver cancer	0.000313	0.000316	CcSEcCtD
Pregabalin—Dry mouth—Epirubicin—liver cancer	0.000312	0.000316	CcSEcCtD
Pregabalin—Vertigo—Doxorubicin—liver cancer	0.000312	0.000315	CcSEcCtD
Pregabalin—Syncope—Doxorubicin—liver cancer	0.000311	0.000315	CcSEcCtD
Pregabalin—Leukopenia—Doxorubicin—liver cancer	0.000311	0.000314	CcSEcCtD
Pregabalin—Confusional state—Epirubicin—liver cancer	0.000309	0.000312	CcSEcCtD
Pregabalin—Palpitations—Doxorubicin—liver cancer	0.000307	0.00031	CcSEcCtD
Pregabalin—Anaphylactic shock—Epirubicin—liver cancer	0.000306	0.000309	CcSEcCtD
Pregabalin—Oedema—Epirubicin—liver cancer	0.000306	0.000309	CcSEcCtD
Pregabalin—Loss of consciousness—Doxorubicin—liver cancer	0.000305	0.000308	CcSEcCtD
Pregabalin—Infection—Epirubicin—liver cancer	0.000304	0.000307	CcSEcCtD
Pregabalin—Cough—Doxorubicin—liver cancer	0.000303	0.000306	CcSEcCtD
Pregabalin—Shock—Epirubicin—liver cancer	0.000301	0.000304	CcSEcCtD
Pregabalin—Convulsion—Doxorubicin—liver cancer	0.000301	0.000304	CcSEcCtD
Pregabalin—Nervous system disorder—Epirubicin—liver cancer	0.0003	0.000303	CcSEcCtD
Pregabalin—Thrombocytopenia—Epirubicin—liver cancer	0.0003	0.000303	CcSEcCtD
Pregabalin—Hypertension—Doxorubicin—liver cancer	0.0003	0.000303	CcSEcCtD
Pregabalin—Tachycardia—Epirubicin—liver cancer	0.000299	0.000302	CcSEcCtD
Pregabalin—Skin disorder—Epirubicin—liver cancer	0.000297	0.000301	CcSEcCtD
Pregabalin—Hyperhidrosis—Epirubicin—liver cancer	0.000296	0.000299	CcSEcCtD
Pregabalin—Arthralgia—Doxorubicin—liver cancer	0.000296	0.000299	CcSEcCtD
Pregabalin—Myalgia—Doxorubicin—liver cancer	0.000296	0.000299	CcSEcCtD
Pregabalin—Chest pain—Doxorubicin—liver cancer	0.000296	0.000299	CcSEcCtD
Pregabalin—Anxiety—Doxorubicin—liver cancer	0.000295	0.000298	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000294	0.000297	CcSEcCtD
Pregabalin—Discomfort—Doxorubicin—liver cancer	0.000292	0.000295	CcSEcCtD
Pregabalin—Anorexia—Epirubicin—liver cancer	0.000292	0.000295	CcSEcCtD
Pregabalin—Dry mouth—Doxorubicin—liver cancer	0.000289	0.000292	CcSEcCtD
Pregabalin—Hypotension—Epirubicin—liver cancer	0.000286	0.000289	CcSEcCtD
Pregabalin—Confusional state—Doxorubicin—liver cancer	0.000286	0.000289	CcSEcCtD
Pregabalin—Oedema—Doxorubicin—liver cancer	0.000283	0.000286	CcSEcCtD
Pregabalin—Anaphylactic shock—Doxorubicin—liver cancer	0.000283	0.000286	CcSEcCtD
Pregabalin—Infection—Doxorubicin—liver cancer	0.000281	0.000284	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000279	0.000282	CcSEcCtD
Pregabalin—Shock—Doxorubicin—liver cancer	0.000279	0.000282	CcSEcCtD
Pregabalin—CACNA1A—Type II diabetes mellitus—TNF—liver cancer	0.000278	0.0272	CbGpPWpGaD
Pregabalin—Nervous system disorder—Doxorubicin—liver cancer	0.000278	0.000281	CcSEcCtD
Pregabalin—Thrombocytopenia—Doxorubicin—liver cancer	0.000277	0.00028	CcSEcCtD
Pregabalin—Insomnia—Epirubicin—liver cancer	0.000277	0.00028	CcSEcCtD
Pregabalin—Tachycardia—Doxorubicin—liver cancer	0.000277	0.000279	CcSEcCtD
Pregabalin—Skin disorder—Doxorubicin—liver cancer	0.000275	0.000278	CcSEcCtD
Pregabalin—Paraesthesia—Epirubicin—liver cancer	0.000275	0.000278	CcSEcCtD
Pregabalin—Hyperhidrosis—Doxorubicin—liver cancer	0.000274	0.000277	CcSEcCtD
Pregabalin—Dyspnoea—Epirubicin—liver cancer	0.000273	0.000276	CcSEcCtD
Pregabalin—Somnolence—Epirubicin—liver cancer	0.000272	0.000275	CcSEcCtD
Pregabalin—Anorexia—Doxorubicin—liver cancer	0.00027	0.000273	CcSEcCtD
Pregabalin—Decreased appetite—Epirubicin—liver cancer	0.000266	0.000269	CcSEcCtD
Pregabalin—Hypotension—Doxorubicin—liver cancer	0.000265	0.000267	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Epirubicin—liver cancer	0.000264	0.000267	CcSEcCtD
Pregabalin—Fatigue—Epirubicin—liver cancer	0.000264	0.000267	CcSEcCtD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—GLUL—liver cancer	0.000263	0.0257	CbGpPWpGaD
Pregabalin—Constipation—Epirubicin—liver cancer	0.000262	0.000265	CcSEcCtD
Pregabalin—Pain—Epirubicin—liver cancer	0.000262	0.000265	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000258	0.000261	CcSEcCtD
Pregabalin—Insomnia—Doxorubicin—liver cancer	0.000256	0.000259	CcSEcCtD
Pregabalin—Paraesthesia—Doxorubicin—liver cancer	0.000254	0.000257	CcSEcCtD
Pregabalin—Dyspnoea—Doxorubicin—liver cancer	0.000253	0.000255	CcSEcCtD
Pregabalin—Feeling abnormal—Epirubicin—liver cancer	0.000252	0.000255	CcSEcCtD
Pregabalin—Somnolence—Doxorubicin—liver cancer	0.000252	0.000254	CcSEcCtD
Pregabalin—Gastrointestinal pain—Epirubicin—liver cancer	0.00025	0.000253	CcSEcCtD
Pregabalin—Decreased appetite—Doxorubicin—liver cancer	0.000246	0.000249	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000245	0.000247	CcSEcCtD
Pregabalin—Fatigue—Doxorubicin—liver cancer	0.000244	0.000247	CcSEcCtD
Pregabalin—Urticaria—Epirubicin—liver cancer	0.000243	0.000246	CcSEcCtD
Pregabalin—Constipation—Doxorubicin—liver cancer	0.000242	0.000245	CcSEcCtD
Pregabalin—Pain—Doxorubicin—liver cancer	0.000242	0.000245	CcSEcCtD
Pregabalin—Body temperature increased—Epirubicin—liver cancer	0.000242	0.000245	CcSEcCtD
Pregabalin—Abdominal pain—Epirubicin—liver cancer	0.000242	0.000245	CcSEcCtD
Pregabalin—CACNA1A—Neuronal System—GLUL—liver cancer	0.000241	0.0235	CbGpPWpGaD
Pregabalin—Feeling abnormal—Doxorubicin—liver cancer	0.000233	0.000236	CcSEcCtD
Pregabalin—Gastrointestinal pain—Doxorubicin—liver cancer	0.000232	0.000234	CcSEcCtD
Pregabalin—Hypersensitivity—Epirubicin—liver cancer	0.000226	0.000228	CcSEcCtD
Pregabalin—Urticaria—Doxorubicin—liver cancer	0.000225	0.000227	CcSEcCtD
Pregabalin—Abdominal pain—Doxorubicin—liver cancer	0.000224	0.000226	CcSEcCtD
Pregabalin—Body temperature increased—Doxorubicin—liver cancer	0.000224	0.000226	CcSEcCtD
Pregabalin—Asthenia—Epirubicin—liver cancer	0.00022	0.000222	CcSEcCtD
Pregabalin—Pruritus—Epirubicin—liver cancer	0.000217	0.000219	CcSEcCtD
Pregabalin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—liver cancer	0.00021	0.0205	CbGpPWpGaD
Pregabalin—Diarrhoea—Epirubicin—liver cancer	0.00021	0.000212	CcSEcCtD
Pregabalin—Hypersensitivity—Doxorubicin—liver cancer	0.000209	0.000211	CcSEcCtD
Pregabalin—Asthenia—Doxorubicin—liver cancer	0.000203	0.000205	CcSEcCtD
Pregabalin—Dizziness—Epirubicin—liver cancer	0.000202	0.000205	CcSEcCtD
Pregabalin—CACNA2D2—Neuronal System—GLUL—liver cancer	0.000202	0.0197	CbGpPWpGaD
Pregabalin—Pruritus—Doxorubicin—liver cancer	0.0002	0.000203	CcSEcCtD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.0002	0.0195	CbGpPWpGaD
Pregabalin—Vomiting—Epirubicin—liver cancer	0.000195	0.000197	CcSEcCtD
Pregabalin—Diarrhoea—Doxorubicin—liver cancer	0.000194	0.000196	CcSEcCtD
Pregabalin—Rash—Epirubicin—liver cancer	0.000193	0.000195	CcSEcCtD
Pregabalin—Dermatitis—Epirubicin—liver cancer	0.000193	0.000195	CcSEcCtD
Pregabalin—Headache—Epirubicin—liver cancer	0.000192	0.000194	CcSEcCtD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00019	0.0186	CbGpPWpGaD
Pregabalin—Dizziness—Doxorubicin—liver cancer	0.000187	0.000189	CcSEcCtD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000183	0.0178	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000183	0.0178	CbGpPWpGaD
Pregabalin—Nausea—Epirubicin—liver cancer	0.000182	0.000184	CcSEcCtD
Pregabalin—Vomiting—Doxorubicin—liver cancer	0.00018	0.000182	CcSEcCtD
Pregabalin—Rash—Doxorubicin—liver cancer	0.000179	0.00018	CcSEcCtD
Pregabalin—Dermatitis—Doxorubicin—liver cancer	0.000178	0.00018	CcSEcCtD
Pregabalin—Headache—Doxorubicin—liver cancer	0.000177	0.000179	CcSEcCtD
Pregabalin—CACNA1A—Calcium Regulation in the Cardiac Cell—PRKCE—liver cancer	0.000177	0.0173	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000173	0.0169	CbGpPWpGaD
Pregabalin—Nausea—Doxorubicin—liver cancer	0.000168	0.00017	CcSEcCtD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—BRAF—liver cancer	0.000121	0.0118	CbGpPWpGaD
Pregabalin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—liver cancer	0.000117	0.0114	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—RAF1—liver cancer	0.000101	0.00985	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—UGDH—liver cancer	0.0001	0.00977	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—EPT1—liver cancer	9.41e-05	0.00919	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—BRAF—liver cancer	9.25e-05	0.00903	CbGpPWpGaD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—ALB—liver cancer	9.04e-05	0.00883	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—TAT—liver cancer	8.92e-05	0.00871	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—CYCS—liver cancer	8.8e-05	0.00859	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—BRAF—liver cancer	8.73e-05	0.00852	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—UGDH—liver cancer	8.39e-05	0.00819	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—EPT1—liver cancer	7.88e-05	0.0077	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—RAF1—liver cancer	7.73e-05	0.00754	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—HMOX1—liver cancer	7.65e-05	0.00747	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—TAT—liver cancer	7.47e-05	0.0073	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—BRAF—liver cancer	7.32e-05	0.00714	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—RAF1—liver cancer	7.29e-05	0.00712	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—BRAF—liver cancer	6.69e-05	0.00653	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—PPARA—liver cancer	6.18e-05	0.00603	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—RAF1—liver cancer	6.11e-05	0.00596	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CPT1B—liver cancer	6.06e-05	0.00592	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GLUL—liver cancer	6.06e-05	0.00592	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—NR1H4—liver cancer	5.85e-05	0.00571	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GSTA3—liver cancer	5.75e-05	0.00561	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—BRAF—liver cancer	5.61e-05	0.00547	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—RAF1—liver cancer	5.59e-05	0.00545	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—HRAS—liver cancer	5.55e-05	0.00542	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GSTA4—liver cancer	5.26e-05	0.00513	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GSTA2—liver cancer	5.12e-05	0.005	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CPT1B—liver cancer	5.08e-05	0.00496	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GLUL—liver cancer	5.08e-05	0.00496	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GSTA1—liver cancer	4.94e-05	0.00483	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—NR1H4—liver cancer	4.9e-05	0.00478	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—NAT2—liver cancer	4.89e-05	0.00477	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GSTA3—liver cancer	4.82e-05	0.0047	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ALDOB—liver cancer	4.69e-05	0.00457	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—RAF1—liver cancer	4.68e-05	0.00457	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—ALB—liver cancer	4.59e-05	0.00448	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CRABP1—liver cancer	4.47e-05	0.00436	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GSTA4—liver cancer	4.41e-05	0.0043	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GSTA2—liver cancer	4.29e-05	0.00419	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—HRAS—liver cancer	4.25e-05	0.00415	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—RAF1—liver cancer	4.15e-05	0.00406	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GSTA1—liver cancer	4.14e-05	0.00404	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—NAT2—liver cancer	4.1e-05	0.004	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—HRAS—liver cancer	4.01e-05	0.00392	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ALDOB—liver cancer	3.93e-05	0.00383	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—HPGDS—liver cancer	3.91e-05	0.00381	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CRABP1—liver cancer	3.75e-05	0.00366	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PSMD10—liver cancer	3.48e-05	0.0034	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PSMA4—liver cancer	3.48e-05	0.0034	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GOT2—liver cancer	3.39e-05	0.00331	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—HRAS—liver cancer	3.36e-05	0.00328	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—HPGDS—liver cancer	3.27e-05	0.0032	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CYP2E1—liver cancer	3.18e-05	0.00311	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—HRAS—liver cancer	3.08e-05	0.003	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CYCS—liver cancer	2.98e-05	0.00291	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GOT1—liver cancer	2.92e-05	0.00285	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GGT1—liver cancer	2.92e-05	0.00285	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PSMA4—liver cancer	2.92e-05	0.00285	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PSMD10—liver cancer	2.92e-05	0.00285	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GOT2—liver cancer	2.84e-05	0.00277	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CYP2E1—liver cancer	2.67e-05	0.00261	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GSTP1—liver cancer	2.63e-05	0.00256	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—HMOX1—liver cancer	2.59e-05	0.00253	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—HRAS—liver cancer	2.58e-05	0.00252	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CYCS—liver cancer	2.5e-05	0.00244	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GOT1—liver cancer	2.45e-05	0.00239	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GGT1—liver cancer	2.45e-05	0.00239	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GSTM1—liver cancer	2.41e-05	0.00236	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CYP1A1—liver cancer	2.29e-05	0.00223	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GSTP1—liver cancer	2.2e-05	0.00215	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—HMOX1—liver cancer	2.17e-05	0.00212	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—MTHFR—liver cancer	2.13e-05	0.00208	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PPARA—liver cancer	2.09e-05	0.00204	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GSTM1—liver cancer	2.02e-05	0.00197	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CYP1A1—liver cancer	1.92e-05	0.00187	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PIK3CG—liver cancer	1.79e-05	0.00175	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—MTHFR—liver cancer	1.79e-05	0.00175	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PPARA—liver cancer	1.75e-05	0.00171	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PPARG—liver cancer	1.73e-05	0.00169	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PIK3CD—liver cancer	1.58e-05	0.00154	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ALB—liver cancer	1.56e-05	0.00152	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PIK3CG—liver cancer	1.5e-05	0.00147	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PPARG—liver cancer	1.45e-05	0.00142	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PIK3CB—liver cancer	1.37e-05	0.00134	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PIK3CD—liver cancer	1.32e-05	0.00129	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ALB—liver cancer	1.3e-05	0.00127	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PIK3CB—liver cancer	1.15e-05	0.00112	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PIK3CA—liver cancer	8.37e-06	0.000817	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PIK3CA—liver cancer	7.02e-06	0.000685	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—AKT1—liver cancer	6.84e-06	0.000668	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—AKT1—liver cancer	5.73e-06	0.00056	CbGpPWpGaD
